Showing 6,141 - 6,160 results of 17,019 for search '"Therapy"', query time: 0.13s Refine Results
  1. 6141

    A fractal–fractional order modeling approach to understanding stem cell-chemotherapy combinations for cancer by Esam Y. Salah, Bhausaheb Sontakke, Ahmed A. Hamoud, Homan. Emadifar, Atul Kumar

    Published 2025-01-01
    “…Abstract The main objective of this work is to study the mathematical model that combines stem cell therapy and chemotherapy for cancer cells. We study the model using the fractal fractional derivative with the Mittag-Leffler kernel. …”
    Get full text
    Article
  2. 6142

    Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India by Mathew John, Ekaterina Koledova, Kanakatte Mylariah Prasanna Kumar, Harshal Chaudhari

    Published 2016-01-01
    “…Availability of an easy-to-use therapy delivery system could also be beneficial in improving adherence and achieving satisfactory outcomes.…”
    Get full text
    Article
  3. 6143
  4. 6144
  5. 6145

    Imatinib-resistance without BCR/ABL Point Mutation in Chronic Myeloid Leukemia by Aytan Shirinova

    Published 2024-03-01
    “…In the future, new molecules for BCR-ABL inhibitors, combination therapy, and molecules entering the blood-brain barrier may improve the outcomes of therapy and prevent imatinib resistance in CML.…”
    Get full text
    Article
  6. 6146

    Effect of Age and Diabetes on the Response of Mesenchymal Progenitor Cells to Fibrin Matrices by A. Stolzing, H. Colley, A. Scutt

    Published 2011-01-01
    “…Mesenchymal stem cells are showing increasing promise in applications such as tissue engineering and cell therapy. MSC are low in number in bone marrow, and therefore in vitro expansion is often necessary. …”
    Get full text
    Article
  7. 6147
  8. 6148

    Pregnancy and Healthy Childbirth in a 37 Year-Old Patient with Diverticular Disease by P. S. Andreev, S. E. Katorkin, O. E. Davydova

    Published 2020-12-01
    “…A high-fibre diet, rifaximin-α at 400 mg twice a day for one week, once a month for six months, and topical anti-inflammatory therapy were prescribed. Clinical symptoms were eradicated upon the treatment. …”
    Get full text
    Article
  9. 6149

    Enhancing caregiver resilience: A systematic review of interventions for chronic disease management by Saeedeh Mohammadi Saber, Behzad Rahimian

    Published 2024-12-01
    “…Quantitative data provides empirical support for the advantages of psychoeducation, mindfulness-based intervention, cognitive behavioral therapy (CBT)-based intervention, and strengthening family coping resources approach, supportive-educational program based on COPE (Coping Orientation to Problems Experienced) model and commitment therapy. …”
    Get full text
    Article
  10. 6150

    Disseminated Nocardia Otitidiscaviarum in a Patient with AIDS by Roger M Sandre, Richard C Summerbell

    Published 1997-01-01
    “…Long term suppressive therapy was needed to prevent relapse.…”
    Get full text
    Article
  11. 6151
  12. 6152

    Memantine-responsive catatonia secondary to tuberculosis, neurocysticercosis, and pneumococcal pneumonia: A case series by Debanjan Bhattacharjee, Ujjwal Bandyopadhyay

    Published 2023-11-01
    “…Benzodiazepines like lorazepam and electroconvulsive therapy are the conventional treatment modalities for catatonia. …”
    Get full text
    Article
  13. 6153

    Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer by Fadi Nabhan, Elizabeth Kander, Rulong Shen, Amit Agrawal, Vineeth Sukrithan, Ye Zhou, Ashima Goyal, Katie Roll, Manisha Shah, Bhavana Konda

    Published 2021-01-01
    “…Immune check point inhibitor (ICI) therapy can be a potentially effective salvage treatment for anaplastic thyroid cancer (ATC) with progression despite standard of care therapies. …”
    Get full text
    Article
  14. 6154

    Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study by A. O. Bueverov, S. V. Koblov, P. O. Bogomolov

    Published 2024-03-01
    “…The data of 47 patients with AIH who received immunosuppressive therapy from April 2001 to August 2023 were analyzed: 10 men (21 %), 37 women (79 %); the average age was 37 (17–66) years. …”
    Get full text
    Article
  15. 6155

    The Relevance of Interventional Time and Clinical Outcomes in Patients with NSTEMI Based on the GRACE Score by Ji-Xiang Wang, Jing Gao, Jian-Yong Xiao, Ming-Dong Gao, Nan Zhang, Peng-Ju Lu, Yin Liu

    Published 2022-01-01
    “…Patients were grouped according to the GRACE score and the time from admission to intervention therapy. The Cox multivariate risk regression model was used to analyze the correlation between the GRACE score and the time from admission to intervention therapy with major adverse cardiovascular events (MACEs). …”
    Get full text
    Article
  16. 6156
  17. 6157

    PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma by San-Chi Chen, Hsiang-Ling Ho, Chien-An Liu, Yi‑Ping Hung, Nai-Jung Chiang, Ming‑Huang Chen, Yee Chao, Muh-Hwa Yang

    Published 2025-02-01
    “…Prothrombin induced by vitamin K absence II (PIVKA-II) is more sensitive for HCC detection, though its role in systemic therapy remains underexplored. This study aimed to evaluate PIVKA-II in non-AFP-secreting HCC treated with systemic therapy. …”
    Get full text
    Article
  18. 6158
  19. 6159

    Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment by Liubov A. Tashireva, Irina V. Larionova, Irina V. Larionova, Nikita A. Ermak, Anastasia A. Maltseva, Ekaterina I. Livanos, Anna Yu. Kalinchuk, Marina N. Stakheyeva, Larisa A. Kolomiets

    Published 2025-01-01
    “…Our review summarizes accumulated data on the role of cells of the tumor microenvironment and their regulatory molecules in the mechanisms underlying therapeutic effects of immune checkpoint inhibitors, including resistance to therapy. Major question we raise here – which group of patients is the most favorable to achieve durable immunotherapy response in endometrial cancer?…”
    Get full text
    Article
  20. 6160

    Harnessing nanotechnology for cancer treatment by Jiajun Zhu, Jiajun Zhu, HaeJu Lee, HaeJu Lee, Ruotong Huang, Ruotong Huang, Jianming Zhou, Jingjun Zhang, Xiaoyi Yang, Wenhan Zhou, Wangqing Jiang, Shuying Chen

    Published 2025-01-01
    “…Nanotechnology has become a groundbreaking innovation force in cancer therapy, offering innovative solutions to the limitations of conventional treatments such as chemotherapy and radiation. …”
    Get full text
    Article